Note: This is a test kit that will be mailed to you and requires a blood draw.
Fasting Required: Yes 10-12 Hours
Specimen: Blood
Special Instructions: Ship to lab Monday-Thursday only.
Results: 5-7 Business Days
Description:
A screening for evidence of cancer in the bloodstream.
This test looks for the following cancer markers:
CEA : Primarily for colorectal cancer, but higher rates will be reported in the following carcinomas:
Pancreas (65-90% of the cases with very high rates)
Lungs (52-77%)
Breast(50%)
Stomach
Thyroid (high rates)
Female genital cancers (25-40%)
CA 19-9 : Initially found in patients with colorectal cancer, CA 19-9 has since been observed and used with pancreas cancer (high to very high rates), stomach cancer (high rates), and bile duct cancer.
CA 125 : CA 125 is the essential ovarian cancer marker.
High rates are also found in cancer of the endometrium and Fallopian tubes. It is also frequently used in small cells lung cancer, together with NSE.
CA 72-4 : Strong new clinical evidence has recently emphasized the clinical value of the CA 72-4 serum tumor marker assay in diagnosis and monitoring of gastric cancer : CA 72-4 is THE stomach cancer tumor marker.
We use it, to be largely complete, with CEA and CA 19-9.
AFP : High rates of AFP strongly suggest presence of primitive liver cancer, or germinating cancer of the ovary or testicle.
BHCG : High rates of beta HCG can point to the presence of testicular cancer; and in varied degrees to cancer of ovary, liver, stomach, pancreas and lung.
Be aware that marijuana consumption leads to increased levels.
PSA/FPSA : PSA is the marker of prostate cancer.
The freePSA/PSA ratio improves the diagnostic differential between prostate-cancer and benign prostate hypertrophy.
B2M : B2M, the beta2microglobulin, is used as a tumor-marker in various illnesses of the haematopoietic system, mainly where B lymphs cells are concerned.
NSE : The main clinical interest of NSE is its marked increase in cases of small cells lung cancer.
It is also used in endocrine pancreas cancer. Also, NSE high levels are involved in neuroblastomas, a smaller increase in medullar thyroid cancer, and a higher (but rarer) value in pheochromocytomas (showing yet malignancy).
CYFRA 21-1 : the “cytokeratin fragment” is the most stunning marker ever discovered. Among all forms of lung cancer (lung cancer presents many different forms), the Cyfra 21-1 delivers an appreciated sensitivity of 65%, and an exceptional specificity of 95%. Its value is closely tied to the stage : levels increase progressively from limited stages to disseminated ones.
Cyfra can also be used in uterine cancer, oesophagus cancer, bladder cancer.
